Interleukin 27 signaling pathways in regulation of immune and autoimmune responses

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 11, 2008, Pages 2379-2383

  Yoshida, Hiroki ^a   Miyazaki, Yoshiyuki ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Autoimmune disease; Helper T cell; IL 10; Interleukin 27

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 27;

ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNITY; CELL POPULATION; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; CYTOKINES; HUMANS; IMMUNE SYSTEM; INTERLEUKINS; RECEPTORS, INTERLEUKIN; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TH1 CELLS;

MUS;

EID: 48349109775     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.05.020     Document Type: Short Survey

References (21)

1. Awasthi A., Carrier Y., Peron J.P., Bettelli E., Kamanaka M., Flavell R.A., et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8 (2007) 1380-1389
2. Batten M., Li J., Yi S., Kljavin N.M., Danilenko D.M., Lucas S., et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7 (2006) 929-936
3. Chen Q., Ghilardi N., Wang H., Baker T., Xie M.H., Gurney A., et al. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 407 (2000) 916-920
4. Fitzgerald D.C., Ciric B., Touil T., Harle H., Grammatikopolou J., Das Sarma J., et al. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol 179 (2007) 3268-3275
5. Fitzgerald D.C., Zhang G.X., El-Behi M., Fonseca-Kelly Z., Li H., Yu S., et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 8 (2007) 1372-1379
6. Hamano S., Himeno K., Miyazaki Y., Ishii K., Yamanaka A., Takeda A., et al. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 19 (2003) 657-667
7. Holscher C., Holscher A., Ruckerl D., Yoshimoto T., Yoshida H., Mak T., et al. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 174 (2005) 3534-3544
8. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201 (2005) 233-240
9. Li J., Gran B., Zhang G.X., Rostami A., and Kamoun M. IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis. J Neurol Sci 232 (2005) 3-9
10. Miyazaki Y., Shimanoe Y., Wang S., and Yoshida H. Amelioration of delayed-type hypersensitivity responses by IL-27 administration. Biochem Biophys Res Commun. 373 (2008) 397-402
11. Neufert C., Becker C., Wirtz S., Fantini M.C., Weigmann B., Galle P.R., et al. IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur J Immunol 37 (2007) 1809-1816
12. Niedbala W, Cai B, Wei X, Patakas A, Leung BP, McInnes IB,et al. (2008). Interleukin-27 attenuates collagen-induced arthritis. Ann Rheum Dis. Epub ahead of print as doi:10.1136/ard.2007.083360.
13. Niedbala W., Wei X.Q., Cai B., Hueber A.J., Leung B.P., McInnes I.B., et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37 (2007) 3021-3029
14. Stumhofer J.S., Laurence A., Wilson E.H., Huang E., Tato C.M., Johnson L.M., et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7 (2006) 937-945
15. Stumhofer J.S., Silver J.S., Laurence A., Porrett P.M., Harris T.H., Turka L.A., et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8 (2007) 1363-1371
16. Sugiyama, N., Nakashima, H., Yoshimura, T., Sadanaga, A., Shimizu, S., Masutani, K., et al. (2007). Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of IL-27R{alpha} (WSX-1). Ann Rheum Dis, Epub ahead of print as doi:10.1136/ard.2007.077537.
17. Takeda A., Hamano S., Yamanaka A., Hanada T., Ishibashi T., Mak T.W., et al. Role of IL-27/WSX-1 signaling for induction of T-Bet through activation of STAT1 during initial Th1 commitment. J Immunol 170 (2003) 4886-4890
18. Villarino A.V., Stumhofer J.S., Saris C.J., Kastelein R.A., de Sauvage F.J., and Hunter C.A. IL-27 limits IL-2 production during Th1 differentiation. J Immunol 176 (2006) 237-247
19. Wang S., Miyazaki Y., Shinozaki Y., and Yoshida H. Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency. J Immunol 179 (2007) 6421-6428
20. Yoshida H., Hamano S., Senaldi G., Covey T., Faggioni R., Mu S., et al. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15 (2001) 569-578
21. Yoshimura T., Takeda A., Hamano S., Miyazaki Y., Kinjyo I., Ishibashi T., et al. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4 + T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4 + T cells partially through STAT3-dependent mechanism. J Immunol 177 (2006) 5377-5385